Cargando…

Age-modified factors associated with placental malaria in rural Burkina Faso

BACKGROUND: Malaria in pregnancy can result in placental infection with fetal implications. This study aimed at assessing placental malaria (PM) prevalence and its associated factors in a cohort of pregnant women with peripheral malaria and their offspring. METHOD: The data were collected in the fra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bihoun, Biébo, Zango, Serge Henri, Traoré-Coulibaly, Maminata, Valea, Innocent, Ravinetto, Raffaella, Van Geertruyden, Jean Pierre, D’Alessandro, Umberto, Tinto, Halidou, Robert, Annie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951713/ https://www.ncbi.nlm.nih.gov/pubmed/35331181 http://dx.doi.org/10.1186/s12884-022-04568-4

Ejemplares similares

Fetal biometry assessment with Intergrowth 21st’s and Salomon’s equations in rural Burkina Faso
por: Bihoun, Biébo, et al.
Publicado: (2020)

Association of malaria and curable sexually transmitted infections with pregnancy outcomes in rural Burkina Faso
por: Zango, Serge Henri, et al.
Publicado: (2021)

Malaria and curable sexually transmitted infections in pregnant women: A two-years observational study in rural Burkina Faso
por: Zango, Serge Henri, et al.
Publicado: (2020)

Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Burkina Faso: an open label trial
por: Birgersson, Sofia, et al.
Publicado: (2020)

Malaria incidence and prevalence during the first year of life in Nanoro, Burkina Faso: a birth-cohort study
por: Natama, Hamtandi Magloire, et al.
Publicado: (2018)

Prevalence and risk factors of malaria among first antenatal care attendees in rural Burkina Faso
por: Lingani, Moussa, et al.
Publicado: (2022)

The impact of clinical research activities on communities in rural Africa: the development of the Clinical Research Unit of Nanoro (CRUN) in Burkina Faso
por: Tinto, Halidou, et al.
Publicado: (2014)

Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso
por: Tahita, Marc C, et al.
Publicado: (2015)

Magnitude of low birthweight in malaria endemic settings of Nanoro, rural Burkina Faso: a secondary data analysis
por: Lingani, Moussa, et al.
Publicado: (2021)

Low birth weight and its associated risk factors in a rural health district of Burkina Faso: a cross sectional study
por: Lingani, Moussa, et al.
Publicado: (2022)

Prospective observational study to evaluate the clinical and biological safety profile of pyronaridine–artesunate in a rural health district in Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2022)

Malaria and curable sexually transmitted and reproductive tract coinfection among pregnant women in rural Burkina Faso
por: Lingani, Moussa, et al.
Publicado: (2021)

An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso
por: Valea, Innocent, et al.
Publicado: (2012)

Polymorphisme de Plasmodium falciparum et mutations des gènes de résistance Pfcrt et Pfmdr1 dans la zone de Nanoro, Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2021)

Optimal Approach and Strategies to Strengthen Pharmacovigilance in Sub-Saharan Africa: A Cohort Study of Patients Treated with First-Line Artemisinin-Based Combination Therapies in the Nanoro Health and Demographic Surveillance System, Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2020)

Genetic variation in the immune system and malaria susceptibility in infants: a nested case–control study in Nanoro, Burkina Faso
por: Natama, Hamatandi Magloire, et al.
Publicado: (2021)

High adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, Nanoro, Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2019)

In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso
por: Lingani, Moussa, et al.
Publicado: (2020)

Household costs associated with seeking malaria treatment during pregnancy: evidence from Burkina Faso and The Gambia
por: Duval, Laetitia, et al.
Publicado: (2022)

Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso
por: Natama, Hamtandi Magloire, et al.
Publicado: (2020)

Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes
por: Valea, Innocent, et al.
Publicado: (2010)

Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial
por: Lingani, Moussa, et al.
Publicado: (2023)

Could the Decision of Trial Participation Precede the Informed Consent Process? Evidence From Burkina Faso
por: Paré Toe, Lea, et al.
Publicado: (2013)

Gender differences in sociodemographic and behavioural factors associated with BMI in an adult population in rural Burkina Faso – an AWI-Gen sub-study
por: Boua, Romuald Palwende, et al.
Publicado: (2018)

Increase in the prevalence of mutations associated with sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso
por: Ruizendaal, Esmée, et al.
Publicado: (2017)

Determinants of Plasmodium falciparum multiplicity of infection and genetic diversity in Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2020)

Associations between prenatal malaria exposure, maternal antibodies at birth, and malaria susceptibility during the first year of life in Burkina Faso
por: Natama, Hamtandi Magloire, et al.
Publicado: (2023)

Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria: a multicentre randomized control trial
por: Nambozi, Michael, et al.
Publicado: (2015)

Assessment of a combined strategy of seasonal malaria chemoprevention and supplementation with vitamin A, zinc and Plumpy’Doz™ to prevent malaria and malnutrition in children under 5 years old in Burkina Faso: a randomized open-label trial (SMC-NUT)
por: Sondo, Paul, et al.
Publicado: (2021)

Impact and operational feasibility of adding malaria infection screening using an ultrasensitive RDT for placental and fetal outcomes in an area of high IPTP-SP coverage in Burkina Faso: the ASSER MALARIA pilot study protocol
por: Tahita, Marc Christian, et al.
Publicado: (2022)

Artemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort study
por: Nambozi, Michael, et al.
Publicado: (2019)

Safety Profile of Drug Use During Pregnancy at Peripheral Health Centres in Burkina Faso: A Prospective Observational Cohort Study
por: Rouamba, Toussaint, et al.
Publicado: (2018)

In Vivo Antiplasmodial Activity of Two Sahelian Plant Extracts on Plasmodium berghei ANKA Infected NMRI Mice
por: Bonkian, Léa Nadège, et al.
Publicado: (2018)

Malaria prevention measures in Burkina Faso: distribution and households expenditures
por: Yaya Bocoum, Fadima, et al.
Publicado: (2014)

Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2016)

Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study
por: Rouamba, Toussaint, et al.
Publicado: (2021)

Asymptomatic malaria and anaemia among pregnant women during high and low malaria transmission seasons in Burkina Faso: household-based cross-sectional surveys in Burkina Faso, 2013 and 2017
por: Rouamba, Toussaint, et al.
Publicado: (2021)

Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change
por: Tinto, Halidou, et al.
Publicado: (2014)

Dynamic of plasmodium falciparum chloroquine resistance transporter gene Pfcrt K76T mutation five years after withdrawal of chloroquine in Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2015)

Patterns of child mortality in rural area of Burkina Faso: evidence from the Nanoro health and demographic surveillance system (HDSS)
por: Noori, Navideh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4jqesc45ov9lo4cqa2h9o9kebh